Approach to patients with diabetes and obesity in primary care

Approach to patients with diabetes and obesity in primary care

Aims: The aim of this study is to analyse the effect of pharmacological and non-pharmacological treatment on weight control in patients with diabetes and obesity. Design: Epidemiological, descriptive, cross-sectional study. Site: Primary care. In 11 health centres in Málaga and Cádiz during April an...

Full description

Bibliographic Details
Main Authors:	Antonio Hormigo Pozo, Desireé Torres Ortega, Antonio J. García Ruiz, José Escribano Serrano, María Escribano Cobalea, Nuria García-Agua Soler
Format:	Article
Language:	Spanish
Published:	Elsevier 2024-02-01
Series:	Atención Primaria
Subjects:	Control de peso Obesidad Diabetes tipo 2 Inhibidor de SGLT2 GLP1 Atención primaria
Online Access:	http://www.sciencedirect.com/science/article/pii/S0212656723002408

Similar Items

Impacto de los inhibidores de SGLT2 sobre la función renal en ancianos con diabetes tipo 2 durante el primer año de tratamiento
by: Leonor P.Silva, et al.
Published: (2022-12-01)

Seguridad en la utilización de gliflozinas en pacientes mayores
by: Elena Fuentes Rodríguez, et al.
Published: (2020-10-01)

Seguridad en la utilización de gliflozinas en pacientes mayores
by: Elena Fuentes Rodríguez, et al.
Published: (2020-10-01)

Inhibidores del SGTL-2 en pacientes con insuficiencia cardiaca y fracción de eyección reducida con o sin diabetes: revisión sistémica
by: Henry Mejia-Zambrano
Published: (2022-04-01)

Inhibidores del SGTL-2 en pacientes con insuficiencia cardiaca y fracción de eyección reducida con o sin diabetes: revisión sistémica
by: Henry Mejia-Zambrano
Published: (2022-04-01)

Morbilidad oculta de prediabetes y diabetes mellitus de tipo 2 en pacientes con sobrepeso y obesos
by: Onidia Mora Linares, et al.
Published: (2013-10-01)

URINARY INFECTIONS ASSOCIATED WITH THE USE OF ISGLT-2
by: Fabiana Vázquez
Published: (2019-08-01)

Lixisenatida en pacientes con diabetes tipo 2 y obesidad: más allá del control glucémico
by: M. Mar Roca-Rodríguez, et al.
Published: (2017-05-01)

Diabéticos sem semaglutido: qual o verdadeiro problema?
by: Sara João, et al.
Published: (2023-03-01)

Diabetes
by: Asociación Colombiana de Endocrinología Diabetes y Metabolismo
Published: (2019-06-01)

Diabetes risk detection study in Primary Care according to FINDRISC questionnaire in the Municipality of Gral. Pueyrredón (DR. DIAP STUDY)
by: Segundo Guzmán Rodríguez, et al.
Published: (2016-12-01)

Resultados de un programa de telemedicina para pacientes con diabetes tipo 2 en atención primaria
by: Jesús López-Torres, et al.
Published: (2015-01-01)

Low glycemic index lunch on satiety in overweight and obese people with type 2 diabetes
by: A. Jiménez-Cruz, et al.

High-Dose Liraglutide and SGLT2 Inhibitor: A Promising Combination
by: Marvin Wei Jie Chua
Published: (2021-12-01)

Glucagon-Like Peptide-2 and the Enteric Nervous System Are Components of Cell-Cell Communication Pathway Regulating Intestinal Na+/Glucose Co-transport
by: Andrew W. Moran, et al.
Published: (2018-10-01)

The treatment of diabetes with new generation drugs
by: Szymon Jan Marosz, et al.
Published: (2020-09-01)

The latest recommendations of the Polish Diabetes Association and the American Diabetes Association in the treatment of diabetes with modern drugs
by: Szymon Marosz, et al.
Published: (2020-09-01)

Exploración del peso corporal en un consultorio médico Screening of body weight at a family physician's office
by: Leonor Hernández Piñero, et al.
Published: (2005-08-01)

Evaluación de un programa de ejercicio físico supervisado en pacientes sedentarios mayores de 65 años con diabetes mellitus tipo 2
by: Javier Parra-Sánchez, et al.
Published: (2015-11-01)

Patrones de prescripción de medicamentos para la diabetes mellitus tipo 2 en cinco departamentos de Colombia, en 2014
by: Noël C. Barengo, et al.
Published: (2018-09-01)

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
by: Usama Abdel Azim Sharaf El Din, et al.
Published: (2022-07-01)

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease
by: Usama Abdel Azim Sharaf El Din, et al.
Published: (2022-07-01)

Manejo de diabetes mellitus tipo 2 con análogos GLP-1: una experiencia real
by: Eduardo José Polanía, et al.
Published: (2018-03-01)

Obesidad: alternativas al paradigma pesocéntrico y patologizante. Primera entrega
by: Nicole Crimer, et al.
Published: (2023-09-01)

El estigma de la obesidad
by: Catalina Moran, et al.
Published: (2022-09-01)

Psychoeducative groups help control type 2 diabetes in a primary care setting
by: Miguel Ángel Cervantes Cuesta, et al.
Published: (2013-04-01)

SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study
by: Zheer Kejlberg Al-Mashhadi, et al.
Published: (2022-08-01)

Risk Factors for Type 2 Diabetes Mellitus in Adolescents from a Doctor's Office
by: Marlene Ferrer Arrocha, et al.
Published: (2022-03-01)

Risk Factors for Type 2 Diabetes Mellitus in Adolescents from a Doctor's Office
by: Marlene Ferrer Arrocha, et al.
Published: (2022-03-01)

Clinical and epidemiological aspects related to microalbuminuria in patients with type 2 diabetes mellitus
by: Reinier Besse Díaz, et al.
Published: (2018-01-01)

Psychosocial factors in adherence to pharmacological treatment and diabetes mellitus control in patients over 65
by: Alfredo Lara-Morales, et al.
Published: (2022-05-01)

Effective Universal Coverage of Diabetes Mellitus Type 2 in Chile
by: Sara Guerrero-Núñez, et al.

Evidencia de mundo real sobre adecuación farmacológica en diabetes tipo 2 y enfermedad cardiovascular
by: Carolina Pintos, et al.
Published: (2023-12-01)

Challenges in obesity research
by: Andreu Palou, et al.
Published: (2013-09-01)

Morbilidad oculta del síndrome metabólico en ancianos con diabetes mellitus de tipo 2
by: Luis Armando García Guerra, et al.
Published: (2013-12-01)

Pensamiento filosófico médico sobre la obesidad
by: Rosa María Real Cancio, et al.
Published: (2021-06-01)

Attempts to lose weight in an overweight and obese population referred to an endocrinology center in Colombia
by: Wandurraga, Edwin Antonio, et al.
Published: (2019-11-01)

Identificación de algunos factores de riesgo en ancianos hipertensos
by: Yarima Beatriz Beatón Lobaina, et al.
Published: (2013-11-01)

Penfigoide ampolloso asociado a vildagliptina
by: S. E. Campbell-Silva, et al.
Published: (2021-03-01)

Obesity and Diabetes
by: Pilar Riobó Serván